Found: 17
Select item for more details and to access through your institution.
Serum MMP-9: a novel biomarker for prediction of clinical relapse in patients with quiescent Crohn's disease, a post hoc analysis.
- Published in:
- Therapeutic Advances in Gastroenterology, 2019, v. 12, p. N.PAG, doi. 10.1177/1756284819881590
- By:
- Publication type:
- Article
Infliximab levels and antibodies in IBD-related peripheral arthralgia.
- Published in:
- International Journal of Colorectal Disease, 2020, v. 35, n. 6, p. 1141, doi. 10.1007/s00384-020-03581-3
- By:
- Publication type:
- Article
Celiac Disease Resolution After Allogeneic Bone Marrow Transplantation is Associated with Absence of Gliadin-Specific Memory Response by Donor-Derived Intestinal T-cells.
- Published in:
- Journal of Clinical Immunology, 2013, v. 33, n. 8, p. 1395, doi. 10.1007/s10875-013-9943-9
- By:
- Publication type:
- Article
Acute Chest Pain as an Infusion Reaction to Vedolizumab.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Prospective Observational Evaluation of the Time-Dependency of Adalimumab Immunogenicity and Drug Concentration in Ulcerative Colitis Patients: the POETIC II Study.
- Published in:
- Journal of Crohn's & Colitis, 2024, v. 18, n. 3, p. 341, doi. 10.1093/ecco-jcc/jjad156
- By:
- Publication type:
- Article
Dose optimisation for Loss of Response to Vedolizumab— Pharmacokinetics and Immune Mechanisms.
- Published in:
- Journal of Crohn's & Colitis, 2021, v. 15, n. 10, p. 1707, doi. 10.1093/ecco-jcc/jjab067
- By:
- Publication type:
- Article
Pharmacokinetics and Immune Reconstitution Following Discontinuation of Thiopurine Analogues: Implications for Drug Withdrawal Strategies.
- Published in:
- Journal of Crohn's & Colitis, 2018, v. 12, n. 12, p. 1410, doi. 10.1093/ecco-jcc/jjy122
- By:
- Publication type:
- Article
Vedolizumab Levels in Breast Milk of Nursing Mothers With Inflammatory Bowel Disease.
- Published in:
- Journal of Crohn's & Colitis, 2018, v. 12, n. 1, p. 120, doi. 10.1093/ecco-jcc/jjx120
- By:
- Publication type:
- Article
Comparable Immune Function Inhibition by the Infliximab Biosimilar CT-P13: Implications for Treatment of Inflammatory Bowel Disease.
- Published in:
- Journal of Crohn's & Colitis, 2017, v. 11, n. 5, p. 593, doi. 10.1093/ecco-jcc/jjw183
- By:
- Publication type:
- Article
Association of Induction Infliximab Levels With Clinical Response in Perianal Crohn’s Disease.
- Published in:
- Journal of Crohn's & Colitis, 2017, v. 11, n. 5, p. 549, doi. 10.1093/ecco-jcc/jjw182
- By:
- Publication type:
- Article
Diet-omics in the Study of Urban and Rural Crohn disease Evolution (SOURCE) cohort.
- Published in:
- Nature Communications, 2024, v. 15, n. 1, p. 1, doi. 10.1038/s41467-024-48106-6
- By:
- Publication type:
- Article
Delaying an infliximab infusion by more than 3 days is associated with a significant reduction in trough levels but not with clinical worsening.
- Published in:
- Therapeutic Advances in Gastroenterology, 2022, v. 15, p. 1, doi. 10.1177/17562848221083395
- By:
- Publication type:
- Article
Do Vedolizumab trough Levels Predict the Outcome of Subsequent Therapy in Inflammatory Bowel Disease?
- Published in:
- Biomedicines, 2023, v. 11, n. 6, p. 1553, doi. 10.3390/biomedicines11061553
- By:
- Publication type:
- Article
Characterization of blood-derived exosomal hTERT mRNA as a biomarker for colon cancer and Lynch syndrome.
- Published in:
- Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.962473
- By:
- Publication type:
- Article
Serum matrix metalloproteinase-7: a potential biomarker in patients with Lynch Syndrome.
- Published in:
- Molecular Biology Reports, 2023, v. 50, n. 9, p. 7471, doi. 10.1007/s11033-023-08614-y
- By:
- Publication type:
- Article
Molecular Landscape of Anti-Drug Antibodies Reveals the Mechanism of the Immune Response Following Treatment With TNFα Antagonists.
- Published in:
- Frontiers in Immunology, 2019, v. 10, p. 1, doi. 10.3389/fimmu.2019.02921
- By:
- Publication type:
- Article
Serum Syndecan-1: A Novel Biomarker for Pancreatic Ductal Adenocarcinoma.
- Published in:
- Clinical & Translational Gastroenterology, 2022, v. 13, n. 5, p. e00473, doi. 10.14309/ctg.0000000000000473
- By:
- Publication type:
- Article